Please Wait
Applying Filters...
menu
    • menu
    Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

    Data Compilation
    #PharmaFlow

    Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

    Stock Recap
    #PipelineProspector

    Menu

    Anagrelide Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 94,844Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    31/10/2025 Alcami
    U.S.A
    		 Takeda Pharmaceutical Company Korea Co., Ltd. 22-4-ND Anagrelide hydrochloride 2009-06-17 Sterling Wisconsin, LLC@[Micronized Process Manufacturing Plant] Powdersize, LLC U.S.A W130 N10497 Washington Drive, Germantown, WI 53022, USA@20 Pacific Drive, Quakertown, PA 18951
    31/10/2025 Cipla
    India
    		 UNUST Co., Ltd. Su4838-7-ND Anagrelide hydrochloride 2010-05-27 Cipla Limited India Virgonagar Post, Old Madras Road, Bangalore - 560 049, INDIA